GIANNELLA, Mario
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 11.969
EU - Europa 5.088
AS - Asia 4.356
SA - Sud America 473
Continente sconosciuto - Info sul continente non disponibili 282
AF - Africa 158
OC - Oceania 46
Totale 22.372
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 11.553
CN - Cina 1.910
SG - Singapore 1.197
RU - Federazione Russa 1.159
DE - Germania 896
IT - Italia 836
BR - Brasile 396
VN - Vietnam 346
CA - Canada 345
UA - Ucraina 342
GB - Regno Unito 328
SE - Svezia 321
HK - Hong Kong 311
FI - Finlandia 301
PL - Polonia 285
FR - Francia 279
TR - Turchia 138
ZA - Sudafrica 117
KR - Corea 114
IE - Irlanda 82
IN - India 79
BD - Bangladesh 64
CZ - Repubblica Ceca 63
JP - Giappone 50
AU - Australia 44
BE - Belgio 42
MX - Messico 40
NL - Olanda 39
EU - Europa 35
AR - Argentina 28
IR - Iran 24
ES - Italia 23
IQ - Iraq 21
EC - Ecuador 15
LT - Lituania 15
EG - Egitto 14
RO - Romania 13
HR - Croazia 12
PK - Pakistan 12
ID - Indonesia 11
CO - Colombia 9
AE - Emirati Arabi Uniti 8
AT - Austria 8
RS - Serbia 8
SA - Arabia Saudita 8
JM - Giamaica 7
MA - Marocco 7
TW - Taiwan 7
VE - Venezuela 7
CH - Svizzera 6
CR - Costa Rica 6
KE - Kenya 6
AL - Albania 5
DZ - Algeria 5
JO - Giordania 5
NP - Nepal 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AZ - Azerbaigian 4
CL - Cile 4
GR - Grecia 4
HN - Honduras 4
HU - Ungheria 4
IL - Israele 4
PA - Panama 4
TH - Thailandia 4
BG - Bulgaria 3
BY - Bielorussia 3
GE - Georgia 3
KG - Kirghizistan 3
KH - Cambogia 3
MY - Malesia 3
UZ - Uzbekistan 3
BO - Bolivia 2
GT - Guatemala 2
LB - Libano 2
LV - Lettonia 2
MK - Macedonia 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
QA - Qatar 2
TN - Tunisia 2
UY - Uruguay 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AD - Andorra 1
AM - Armenia 1
AO - Angola 1
BH - Bahrain 1
BS - Bahamas 1
BZ - Belize 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
GA - Gabon 1
GH - Ghana 1
IS - Islanda 1
KZ - Kazakistan 1
Totale 22.112
Salva come PNG Salva come JPEG
Città #
Dallas 995
Jacksonville 837
Ashburn 832
Woodbridge 820
Chandler 671
Singapore 656
Fairfield 652
San Jose 540
Ann Arbor 534
Wilmington 434
Houston 416
Council Bluffs 403
Beijing 339
Boardman 327
Hong Kong 305
Nanjing 281
Seattle 273
Toronto 212
Los Angeles 200
Cambridge 196
Dearborn 191
The Dalles 163
New York 160
Warsaw 159
Helsinki 147
Düsseldorf 140
San Mateo 133
Ho Chi Minh City 125
Kraków 121
Seoul 109
Columbus 107
Lawrence 107
Tongling 107
Johannesburg 106
Princeton 106
Camerino 100
Istanbul 100
Nanchang 97
Lauterbourg 96
Buffalo 89
Munich 89
Dublin 81
Moscow 77
Ogden 77
Shanghai 70
Hanoi 69
Santa Clara 69
Kunming 68
London 68
Lachine 67
Shenyang 66
Orem 59
Tianjin 51
São Paulo 48
Brno 47
Guangzhou 46
Jiaxing 46
Turku 45
Hebei 44
Milan 44
Venezia 44
Brussels 42
Chicago 40
Changsha 39
Tokyo 37
Jinan 34
Phoenix 34
Denver 32
San Diego 32
Hangzhou 31
Chennai 29
Montreal 29
Redwood City 29
Philadelphia 28
Washington 27
Zhengzhou 26
Poplar 25
Wuhan 25
Falls Church 24
Frankfurt am Main 24
Venice 24
Brooklyn 23
Boston 22
Hefei 21
Stockholm 21
Sydney 21
Taizhou 20
Da Nang 19
Leawood 19
Mexico City 19
Amsterdam 18
Manchester 18
Atlanta 17
Ningbo 17
Nürnberg 17
Orange 17
Ankara 16
Monmouth Junction 16
Redondo Beach 16
Fuzhou 15
Totale 14.624
Salva come PNG Salva come JPEG
Nome #
1,4-DIOXANE NUCLEUS AS A SUITABLE SCAFFOLD FOR NOVEL D2-LIKE RECEPTOR LIGANDS 634
1,4-Dioxane, a Suitable Scaffold for the Development of Novel M3 Muscarinic Receptor Antagonists 631
1,4-Dioxane ring as a promising template of novel 5-HT1A full agonists 568
1'-Benzyl-3,4-dihydrospiro[2H-1-benzothiopyran-2,4'-piperidine] (Spipethiane), a potent and highly selective sigma1 lingand 561
Antagonism/Agonism modulation to build novel antihypertensives selectively triggering i1-imidazoline receptor activation 344
The Versatile 2-Substituted Imidazoline Nucleus as a Structural Motif of Ligands Directed to the Serotonin 5-HT1A Receptor 336
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 330
A Novel Class of Dopamine D4 Receptor Ligands Bearing an Imidazoline Nucleus 303
Combined Interactions with I1-, I2-Imidazoline Binding Sites and α2-Adrenoceptors To Manage Opioid Addiction 295
Novel ligands rationally designed for characterizing I2-imidazoline binding sites nature and functions 274
33rd camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 273
2-(2-Phenylcyclopropyl)imidazolines: Reversed Enantioselective Interaction at I1 and I2 Imidazoline Receptors 267
Favourable involvement of α2A-adrenoreceptor antagonism in the I₂-imidazoline binding sites-mediated morphine analgesia enhancement. 254
The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over α1-adrenoceptor and D2-like receptor subtypes 253
Multitarget 1,4-Dioxane Compounds Combining Favorable D2-like and 5-HT1A Receptor Interactions with Potential for the Treatment of Parkinson's Disease or Schizophrenia 247
Biological profile and bioavailability of imidazoline compounds on morphine tolerance modulation 245
Receptor Ligands as Helping Hands to L-DOPA in the Treatment of Parkinson's Disease 244
14th Camerino-Noordwijkerhout Symposium - Ongoing Progress in Receptor Chemistry 243
alpha(2)-Adrenoreceptors profile modulation. 2. Biphenyline analogues as tools for selective activation of the alpha2C-subtype 242
Identification of 2-aminopyrimidine derivatives as inhibitors of the canonical Wnt signaling pathway 235
Binding of nicotine and homoazanicotine analogues at neuronal nicotinic acetylcholinergic (nACh) receptors 233
Imidazoline binding sites (IBS) profile modulation: Key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues 231
33rd Camerino-Cyprus Symposium - Receptor Chemistry: Reality and Vision 229
Deoxamuscaroneoxime Devatives as useful Muscarinic Aginist to Explore the Muscarinic Subsite: Demox, Amodulator of Orthosteric and Allosteric Site at Cardiac Muscarinic M2 Receptors. 228
Discovery of Highly Selective Imidazoline Receptor Ligands 228
Novel 1,4-dioxane derivatives as NMDA receptor channel blockers 226
Structure-activity relationships in 1,4-benzodioxan-related compounds. Investigation on the role of the dehydrodioxane ring on alpha1-adrenoreceptor blocking activity 223
77-LH-28-1 as a model for the rational design of selective dopamine D4 receptor ligands 223
Role of the NMDA Receptor in the Antitumor Activity of Chiral 1,4-Dioxane Ligands in MCF-7 and SKBR3 Breast Cancer Cells 222
Structure−Activity Relationships in 1,4-Benzodioxan-Related Compounds. 11.1 Reversed Enantioselectivity of 1,4-Dioxane Derivatives in α1‑Adrenergic and 5‑HT1A Receptor Binding Sites Recognition 220
Novel Highly Potent and Selective σ1 Receptor Antagonists Related to Spipethiane 219
3-Phenyl analogues of 2-[[[2-(2,6-Dimethoxyphenoxyethyllamino]methyl]-1,4-benzodioxan (WB 4101) as highly selective alpha1-adrenoreceptor antagonists1 218
Design, synthesis and muscarinic activity of deoxamuscarine-related derivatives 218
Structure-activity relationships in 1,4-benzodioxan-related compounds. 7. Selectivity of 4-phenylchroman analogues for alpha(1)-adrenoreceptor subtypes 216
31st Camerino-Cyprus-Noordwijkerhout Symposium - Receptor Chemistry Skyline 215
Synthesis and muscarinic properties of (1S*,3R*,5R*)-trimethyl(1-methyl-6-oxabicyclo[3.1.0]hex-3-yl)methyl ammonium iodide 214
Rapid novel divergent synthesis and muscarinic agonist profile of all four optical isomers of N,N,N-trimethyl(6-methyl-1,4-dioxan-2-yl)methanaminium iodide. 212
Muscarinic subtypes profile modulation within a series of new antagonists, bridged bicyclic derivatives of 2,2-diphenyl-[1,3]-dioxolan-4-ylmethyl-dimethylamine 210
Homoazanicotine: A structure-affinity study for nicotinic acetylcholine (nACh) receptor binding 210
16th Camerino-Noordwijkerhout Symposium - An Overview of Receptor Chemistry 208
Low doses of allyphenyline and cyclomethyline, effective against morphine dependence, elicit an antidepressant-like effect 208
Alpha(2)-Adrenoreceptors Profile Modulation. 3. (R)-(+)-m-Nitrobiphenyline, a New Efficient and alpha(2C)-Subtype Selective Agonist. 207
Might Adrenergic alpha2C-agonists/alpha2A-antagonists become novel therapeutic tools for pain treatment with morphine? 207
Properly substituted 1,4-dioxane nucleus favours the selective M3 muscarinic receptor activation 204
28th Camerino-Cyprus-Noordwijkerhout Symposium - Trekking through Receptor Chemistry 204
Use of frozen sections for the pharmacological characterization of compounds active on neurotransmitter receptors 203
BIOLOGICAL PROFILE AND BIOAVAILABILITY OF IMIDAZOLINE COMPOUNDS AFFECT THEIR MODULATORY ACTIVITY ON MORPHINE TOLERANCE 202
4WD to Travel Inside the 5-HT1A Receptor World 201
Enantioselective interactions to improve adrenergic α2C-agonism/α2A-antagonism 198
Potent muscarinic antagonists bearing 1,4-dioxane scaffold 197
Chain-lengthened and imidazoline analogues of nicotine 195
Solution-phase synthesis of ICG-001, a beta-turn peptidomimetic molecule inhibitor of beta-catenin-Tcf-mediated transcription 195
Exploring multitarget interactions to reduce opiate withdrawal syndrome and psychiatric comorbidity 195
Alpha(2)-adrenoreceptors profile modulation and high antinociceptive activity of (S)-(-)-2-[1-(biphenyl-2-yloxy)ethyl]-4,5-dihydro-1H-imidazole 194
Allyphenyline analogues potentially useful in the management of chronic pain and opioid addiction. 194
Muscarinic Thioligands with Cyclopentane Nucleus 194
The Camerino symposium series (1978-2013): a privileged observatory of receptorology development 192
NOVEL BIVALENT LIGANDS OF XANOMELINE AND 77-LH-28-1 AS POTENTIAL M1 MUSCARINIC AGONISTS 192
Novel Potent 5-HT1a Agonists Selective over alpha1-Adrenoceptor Subtypes 191
Dioxane and Oxathiane Nuclei: Suitable Substructures for Muscarinic Agonists 188
Age-related Changes in the Density of Muscarinic Cholinergic M1 and M2 Receptor Subtypes in Pyramidal Neurons or the rat Hippocampus 188
DOPAMINE D2, D3, AND D4 RECEPTOR AFFINITIES OF 77-LH-28-1 AND ITS ANALOGUES 188
Ligand binding to I2 imidazoline receptor: the role of lipophilicity in quantitative structure-activity relationship models 187
Fruitful Adrenergic alpha(2C)-Agonism/alpha(2A)-Antagonism Combination to Prevent and Contrast Morphine Tolerance and Dependence 186
Synthesis, Absolute Configuration, and Biological Profile of the Enantiomers of trans-[2-(2,6-Dimethoxypheoxy)ethyl] [(3-p-tolyl-2,3-dihydro-1,4-benzodioxin-2-yl)methyl]amine (Mephendioxan), a Potent Competitive alpha 1A-Adrenoreceptor Antagonist 185
TESTING D2-LIKE RECEPTOR AFFINITY AND SELECTIVITY WITH NOVEL IMIDAZOLINE DERIVATIVES 185
Agonists and antagonists targeting the different alpha(2)-adrenoceptor subtypes 183
Structure-activity relationships in 1,4-benzodioxan-related compounds. 8.(1) {2-[2-(4 chlorobenzyloxy)phenoxy]ethyl}-[2-(2,6-dimethoxyphenoxy)ethyl]amine (clopenphendioxan) as a tool to highlight the involvement of alpha1D- and alpha1B-adrenoreceptor subtypes in the regulation of human PC-3 prostate cancer cell apoptosis and proliferation 182
alpha(2)-adrenoreceptors profile modulation. 4. From antagonist, to agonist behavior 180
Pharmacophore development and 3D-QSAR study of I1 imidazoline binding site ligands 178
Structure-activity relationships in 1,4-benzodioxan-related compounds. 9.From 1,4-benzodioxan to 1,4-dioxane ring as a promising template of novel alpha(1D)-adrenoreceptor antagonists, 5-HT1A full agonists, and cytotoxic agents. 178
Imidazoline receptors: Qualitative structure-activity relationships and discovery of tracizoline and benazoline. Two ligands with high affinity and unprecedented selectivity 178
The 2-substituted imidazoline ring linked to an aromatic moiety by a biatomic bridge: a bioversatile scaffold 177
Might adrenergic α2C-agonist/α2A-antagonist become a novel therapeutic multitarget tool for morphine chronic treatment of pain? 176
MORPHINE TOLERANCE MODULATION INDUCED BY alpha2-ADRENERGIC OR/AND I2 IMIDAZOLINE BINDING SITES LIGANDS 176
Rational design of novel I1-imidazoline receptor agonists 175
Advances in drug design and therapeutic potential of selective or multitarget 5‐HT1A receptor ligands 171
Imidazoline nucleus as a biologically versatile scaffold 170
From benzodioxane to 1,4-dioxane scaffold in the design of 5-HT1A serotoninergic full agonists from α1-adrenergic antagonists 169
I recettori adrenergici 169
Byciclic dioxolanes as potential antimuscarinic agents 169
Structure- Activity Relationships in 1,4-Benzodioxan-related Compounds. 4. Effect of aryl and alkyl Substituents at Position 3 on α-adrenoreceptor blocking activity 164
Synthesis and muscarinic activity of some muscarone analogs 163
Hybrid molecules from xanomeline and 77-LH-28-1 as potential novel M1 muscarinic agonists 161
Rational design of new alpha(2)-adrenoreceptor agonists 159
NOVEL IMIDAZOLINE MOLECULES INSPIRED BY THE PHARMACOLOGICAL PROFILE OF AGMATINE AS POTENTIAL TOOLS IN MANAGING OPIOID ADDICTION 156
Structure-Activity Relationships in 1,4-Benzodioxan-Related Compounds. 6. Role of the Dioxane Unit on Selectivity for Alpha1-Adrenoreceptor Subtypes 149
Molecular determinants in the binding of novel 1,4-benzodioxan-related α1D-adrenergic receptor antagonists: a computational study 149
Design and synthesis of novel imidazoline derivatives potentially targeting dopamine receptors 148
Binding of Tracizolines to the Imidazoline Receptor. Role of Lipophilicity in Quantitative Structure-Activity Relationship Models. 148
Aminopyrimidines as inhibitors of the Wnt signalling pathway 145
Novel muscarinic antagonists designed on the 1,4-dioxane scaffold 145
Enantiomers of 6,6-diphenyl-1,4-dioxane derivatives to highlight stereochemical requirements for selective alpha1D-AR and 5- HT1A receptor recognition 142
Copresence of 1,4-dioxane and quinuclidine nuclei in the design of novel muscarinic antagonists 138
Structure-activity relationships in 1,4-benzodioxan-related compounds. 10. Novel alpha1-adrenoreceptor antagonists related to openphendioxan: synthesis, biological evaluation, and alpha1d computational study 137
Might the observed alpha2A-adrenoreceptor agonism or antagonism of allyphenyline analogues be ascribed to different molecular conformations? 135
Structure- Activity Relationships in 1,4-Benzodioxan-related Compounds. 5. Effects of Modification of the side chain on alpha-adrenoreceptor blocking Activity 129
Novel α1-adrenoreceptor antagonists related to openphendioxan: biological evaluation and α1d computational study 128
ANTIDEPRESSANT-LIKE ACTIVITY OF NOVEL IMIDAZOLINE LIGANDS DIRECTED TO THE SEROTONIN 5-HT1A RECEPTOR 127
Coupling of I-1 Imidazoline Receptors to the cAMP Pathway: Studies with a Highly Selective Ligand, Benazoline 126
Totale 21.642
Salva come PNG Salva come JPEG
Categoria #
all - tutte 83.446
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 83.446
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022760 0 0 14 78 83 61 29 77 86 125 76 131
2022/20231.704 200 67 71 269 183 227 10 105 313 97 108 54
2023/20241.105 167 63 74 33 46 97 45 17 113 40 25 385
2024/20253.507 142 80 283 168 88 193 427 825 296 225 245 535
2025/20265.791 323 396 1.144 748 605 440 808 323 278 299 259 168
2026/2027623 288 161 174 0 0 0 0 0 0 0 0 0
Totale 22.372